{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:24:57Z","timestamp":1780637097370,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/bf03160902","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T10:52:46Z","timestamp":1251370366000},"page":"26-29","source":"Crossref","is-referenced-by-count":17,"title":["Unusual presentation of iatrogenic phenytoin toxicity in a newborn"],"prefix":"10.1007","volume":"1","author":[{"given":"Jennifer A.","family":"Lowry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Vandover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"DeGreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03160902_CR1","unstructured":"Anonymous. American Academy of Pediatrics: Committee on Drugs and Committee on Hospital Care. Pediatrics.1998;102:428."},{"key":"BF03160902_CR2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1542\/peds.102.5.1223","volume":"102","author":"J Sharfstein","year":"1998","unstructured":"Sharfstein J, Agrawal D, Jeffrey P. Letter to the editor. Pediatrics.1998;102:1223.","journal-title":"Pediatrics"},{"key":"BF03160902_CR3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0196-0644(05)81604-X","volume":"20","author":"C Wyte","year":"1991","unstructured":"Wyte C, Berk WA. Severe oral phenytoin overdose does not cause cardiovascular mortality. Ann Emerg Med.1991;20:508.","journal-title":"Ann Emerg Med."},{"key":"BF03160902_CR4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2165\/00003088-199018020-00004","volume":"18","author":"RL Nation","year":"1990","unstructured":"Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (Part II). Clin Pharmacokinet.1990;18:131.","journal-title":"Clin Pharmacokinet."},{"key":"BF03160902_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/DMDI.1996.13.2.155","volume":"13","author":"T Sarich","year":"1996","unstructured":"Sarich T, Wright JM. Hypothyroxinemia and phenytoin toxicity: A vicious circle. Drug Metabol Drug Interact.1996;13:155.","journal-title":"Drug Metabol Drug Interact"},{"key":"BF03160902_CR6","first-page":"119","volume":"14","author":"SQ Zhu","year":"1994","unstructured":"Zhu SQ, Liu XM, Ruan XZ, Cai Z. Changes of thyroid hormone levels in epileptic patients. J Tongji Med Univ.1994;14:119.","journal-title":"J Tongji Med Univ."},{"key":"BF03160902_CR7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00004836-199201000-00014","volume":"14","author":"G Bassotti","year":"1992","unstructured":"Bassotti G, Pagliacci MC, Nicoletti I, Pelli MA, Morelli A. Intestinal pseudo-obstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol.1992;14:56.","journal-title":"J Clin Gastroenterol."},{"key":"BF03160902_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-2008-1063392","volume":"2","author":"S Goto","year":"1992","unstructured":"Goto S, Billmire DF, Grosfeld JL. Hypothyroidism impairs colonic motility and function. An experimental study in the rat. Eur J Pediatr Surg.1992;2:16.","journal-title":"Eur J Pediatr Surg."},{"key":"BF03160902_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00003088-199529050-00004","volume":"29","author":"D Battino","year":"1995","unstructured":"Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Clin Pharmacokinet.1995;29:341.","journal-title":"Clin Pharmacokinet."},{"key":"BF03160902_CR10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/j.1552-4604.1994.tb01999.x","volume":"34","author":"MJ Painter","year":"1994","unstructured":"Painter MJ, Minnigh MB, Gaus L, Scher M, Brozanski B, Alvin J. Neonatal phenobarbital and phenytoin binding profiles. J Clin Pharmacol.1994;34:312.","journal-title":"J Clin Pharmacol."},{"key":"BF03160902_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0031-3955(05)70463-6","volume":"44","author":"JS Leeder","year":"1997","unstructured":"Leeder JS, Kearns GL. Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am.1997;44:55.","journal-title":"Pediatr Clin North Am."},{"key":"BF03160902_CR12","first-page":"207","volume":"46","author":"K Bachmann","year":"1984","unstructured":"Bachmann K, Schwartz JI, Forney RB, Jaurgeui L. Single dose phenytoin clearance during erythromycin treatment. Research Communications in Chemical Pathology and Pharmacology.1984;46:207.","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"BF03160902_CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/14.1.165","volume":"14","author":"RM Tucker","year":"1992","unstructured":"Tucker RM, Denning DW, Hanson LH, Rinaldi MG, Graybill JR, Sharkey PK, et al. Interaction of azoles with rifampin, phenytoin, and carbamazepine: In vitro and clinical observations. Clin Infect Dis.1992;14:165.","journal-title":"Clin Infect Dis."},{"key":"BF03160902_CR14","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1001\/jama.1977.03270510052024","volume":"237","author":"JQ Rose","year":"1977","unstructured":"Rose JQ, Choi HK, Schentag JJ, Kinkel WR, Jusko WJ. Intoxication caused by interaction of chloramphenicol and phenytoin. JAMA.1977;237:2630.","journal-title":"JAMA"},{"key":"BF03160902_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00003495-198020010-00004","volume":"20","author":"AJ Bint","year":"1980","unstructured":"Bint AJ, Burtt I. Adverse antiobiotic drug interactions. Drugs.1980;20:57.","journal-title":"Drugs"},{"key":"BF03160902_CR16","first-page":"536","volume":"41","author":"RS Chandra","year":"1993","unstructured":"Chandra RS, Dalvi SS, Powar HS, Karnad PD, Kshirsagar NA. Phenytoin toxicity due to rifampicin induced hepatic dysfunction. JAPI.1993;41:536.","journal-title":"JAPI"},{"key":"BF03160902_CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/clinchem\/37.1.98","volume":"37","author":"A Dasgupta","year":"1991","unstructured":"Dasgupta A, Dennen DA, Dean R, McLawhorn RW. Displacement of phenytoin from serum protein carriers by antibiotics: Studies with ceftriaxone, nafcillin, and sulfamethoxazole. Clin Chem.1991;37:98.","journal-title":"Clin Chem."},{"key":"BF03160902_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/j.1875-9114.1997.tb03723.x","volume":"17","author":"A Dasgupta","year":"1997","unstructured":"Dasgupta A, Sperelakis A, Mason A, Dean R. Phenytoin-oxacillin interactions in normal and uremic sera. Pharmacother.1997;17:375.","journal-title":"Pharmacother."},{"key":"BF03160902_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/bdd.2510050304","volume":"5","author":"K Arimori","year":"1984","unstructured":"Arimori K, Nakano M, Otagiri M, Uekama K. Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivo. Biopharm Drug Dispos.1984;5:219\u201327.","journal-title":"Biopharm Drug Dispos."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03160902\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03160902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T03:57:52Z","timestamp":1710561472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03160902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF03160902"],"URL":"https:\/\/doi.org\/10.1007\/bf03160902","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}